Antidiuretic action of clofibrate
Baïsset, A.; Cotonat, J.; Dumas, J.C.; Montastruc, P.
Therapie 28(4): 651-661
1973
ISSN/ISBN: 0040-5957 PMID: 4793685 Document Number: 69675
Document emailed within 1 workday
Related Documents
Mertz, D.P. 1980: Clofibrate therapy in hypercholesterolemia. Reports on medium-long-term movements of HDL- cholesterol by the action of clofibrate Fortschritte der Medizin 98(45): 1761-1766Fabre, J.; Denizot, M.; Wildi, E.; Micheli, H.; Berthoud, S. 1973: Hypolipemic property and myotoxic action of clofibrate in a case of nephrotic syndrome Schweizerische Rundschau für Medizin Praxis 62(23): 732-737
Salvetti, A.; Arzilli, P.; Russo, R. 1973: On the antidiuretic action of angiotensin Ii and of furosemide in a case of renal diabetes insipidus Minerva Pediatrica 25(27): 1198-1201
Schwartzkopff, W. 1979: Clofibrate banned - what now? Münchener Medizinische Wochenschrift 121(15): 529-533
Macela, A. 1970: Clofibrate Spofa Casopis Lekaru Ceskych 109(30): 700-701
Kra, S.J. 1974: Muscle syndrome with clofibrate usage Connecticut Medicine 38(7): 348-349
Holzgreve, H. 1979: Clofibrate prohibition: a wrong decision? Münchener Medizinische Wochenschrift 121(2): 43-44
Jung, W.; Kremer, G.J.; Müller, D. 1975: Clofibrate treatment of diabetics with hyperproteinemias Münchener Medizinische Wochenschrift 117(44): 1783-1786
Bojs, G.; Fahlén, M.; Lapidus, L. 1979: Clofibrate-induced muscle problems Lakartidningen 76(30-31): 2631-2632
Mertz, D.P.; Suermann, I.; Göhmann, E. 1978: Clofibrate in type IIa hyperlipoproteinemia. Reduction of apolipoprotein B Münchener Medizinische Wochenschrift 120(34): 1097-1099
Datta, T. 1980: Clofibrate for treatment of diarrhea in infancy and childhood Indian Pediatrics 17(2): 205
Lücker, P.W.; Wetzelsberger, K.; Erking, W.; Donike, M. 1980: Metabolism and pharmacokinetics of etofylline clofibrate, new antilipemic Arzneimittel-Forschung 30(11b): 2045-2053
Hartlapp, J.H.; Kürten, J.; Gugler, R. 1978: Metabolism of clofibrate in hepatitis and liver cirrhosis Verhandlungen der Deutschen Gesellschaft für Innere Medizin 84: 1108-1110
Carapezzi, C.; Palummeri, E.; Soncini, G.; Bastoni, L.; Passeri, M. 1976: Influence of clofibrate on carbohydrate metabolism in diabetics Giornale di Clinica Medica 57(3-4): 113-125
Oláh, Z. 1971: Use of Clofibrate SPOFA in the treatment of diabetic retinopathy Ceskoslovenska Oftalmologie 27(5): 315-318
Gilbert, R.D. 1973: Inappropriate antidiuretic hormone Annals of Internal Medicine 78(3): 462
Nye, E.R.; Sutherland, W.H.; Temple, W.a. 1980: The treatment of hyperlipoproteinaemia with gemfibrozil compared with placebo and clofibrate New Zealand Medical Journal 92(671): 345-349
Uekama, K.; Oh, K.; Otagiri, M.; Seo, H.; Tsuruoka, M. 1983: Improvement of some pharmaceutical properties of clofibrate by cyclodextrin complexation Pharmaceutica Acta Helvetiae 58(12): 338-342
Popova, S.V.; Antonenkov, V.D.; Panchenko, L.F. 1983: Characterization of clofibrate-stimulated alkaline phosphatase in rat liver Voprosy Meditsinskoi Khimii 29(4): 78-83
Bellotti, L.; Frigo, G. 1983: Quantitative simultaneous determination with HPLC of clofibrate and pyridinolcarbamate Bollettino Chimico Farmaceutico 122(3): 143-148